ClinicalTrials.gg
RecruitingNCT07677826Effect of CoeUpdated Jul 1, 2026

Effect of Co-enzyme Q10 and Vitamin C Alone or in Combination After a Surgical Gingival Depigmentation

An interventional study of surgical depigmentation and Coenzyme Q10 in Depigmentation Treatment and Depigmentation, sponsored by Al-Azhar University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Mar 2026, registered Jun 2026).
  • Started Mar 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This study aims to assess the clinical effectiveness of Co-enzyme Q10 and Vitamin C, applied individually or in combination after surgical gingival depigmentation.

02

Conditions studied

  • Depigmentation Treatment
  • Depigmentation

Browse trials for

03

In context

Vitiligo

343 studies on the registry are indexed under Vitiligo; 96 are open to participants now.

This study's planned enrollment of 20 is below the median of 36 across 265 interventional studies indexed under Vitiligo.

Browse Vitiligo studies →

Lead sponsor

Al-Azhar University is the lead sponsor of 531 studies on the registry; 172 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Systemically healthy patient of both genders aged from 18-45 years.
  • Presence of bilateral physiologic gingival pigmentation in the anterior maxillary or mandibular region DOPI grades III-IV only.
  • Good oral hygiene.
  • Thick gingival phenotype.

Exclusion criteria

Exclusion Criteria:

  • Patient clinically diagnosed with periodontitis.
  • Pregnant or lactating females.
  • Patient with previous treatment of gingival hyperpigmentation.
  • History of to any study material.
  • Patients who are active or previous smokers.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    control

    Surgical Depigmentation Alone

    Procedure: surgical depigmentation

  • Experimental
    test I

    Surgical Depigmentation + CoQ10

    Procedure: surgical depigmentation · Dietary Supplement: Coenzyme Q10

  • Experimental
    Test II

    Surgical Depigmentation + Vitamin C

    Procedure: surgical depigmentation · Dietary Supplement: Vitamin C

  • Experimental
    Test III

    Surgical Depigmentation + CoQ10 + Vitamin C

    Procedure: surgical depigmentation · Dietary Supplement: Surgical Gingival Depigmentation Coenzyme Q10 Vitamin C

Interventions

  • Proceduresurgical depigmentation

    Surgical gingival depigmentation performed using the conventional scalpel technique. The pigmented gingival epithelium is surgically removed under local anesthesia to eliminate melanin pigmentation and improve gingival esthetics.

  • Dietary supplementCoenzyme Q10

    Coenzyme Q10 administered according to the study protocol following surgical gingival depigmentation to evaluate its effect on wound healing and gingival depigmentation.

  • Dietary supplementVitamin C

    Vitamin C administered according to the study protocol following surgical gingival depigmentation to evaluate its effect on wound healing and gingival depigmentation.

  • Dietary supplementSurgical Gingival Depigmentation Coenzyme Q10 Vitamin C

    Coenzyme Q10 and vitamin c administered according to the study protocol following surgical gingival depigmentation to evaluate its effect on wound healing and gingival repigmentation.

06

What researchers measure

Primary outcomes

  1. Change in gingival pigmentation intensity using the Dummett Oral Pigmentation Index (DOPI). The DOPI scale from 0 to 3, where:0 = No clinical pigmentation ,1 = Mild pigmentation , 2 = Moderate pigmentation 3 = Heavy pigmentation

    Change in gingival pigmentation intensity that measured by using a standardized gingival pigmentation index (DOPI)

    Time frame: 1 week, 1 month and 3 months. ,6 months

07

Study locations

1 of 1 sites recruiting
  • Faculty of dental medicine for girls? ALAZHAR University, Cairo, egypt
    Nāşir, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07677826
Responsible party
Nora Abdelgawad Mohamed (associate professor of oral medicine and periodontology, Al-Azhar University) — Principal investigator
First posted
Jul 1, 2026
Start date
Mar 2, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 20, 2026 (estimated)
Last update
Jul 1, 2026

Study contacts

nora abdelgawad associate professor, phd
Contact
noramohamed.26@azhar.edu.eg
+201019407891
nora abdelgawad abdelgawad, phd
Contact
021019407891

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Coenzyme Q10 · Ascorbic Acid

Start the discussion